Ets1 was significantly activated by ERK1/2 in mutant K-ras stably transfected human adrenocortical cells

DNA and Cell Biology

Volumn 24, Issue 2, 2005, Pages 126-132

  Chen, Y F ^a   Shin, S J ^b   Lin, S R ^a,b  

^a MedicoGenomic Research Center   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERSTITIAL COLLAGENASE; ISOPROPYL THIOGALACTOSIDE; K RAS PROTEIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUTANT PROTEIN; PROLACTIN; PROTEIN; PROTEIN BCL 2; PROTEIN ETS1; PROTEIN MATRIX METALLOPROTEINASE 3; PROTEIN UPA; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS; WESTERN BLOTTING;

ADRENAL CORTEX; ADRENAL CORTEX NEOPLASMS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION PROFILING; HUMANS; MATRIX METALLOPROTEINASE 3; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROLACTIN; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; PROTO-ONCOGENE PROTEINS P21(RAS); TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

MOLVA MOLVA;

EID: 13244295390     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2005.24.126     Document Type: Article

References (29)

1. BALLSCHMIETER, P., BRAIG, M., LINDEMANN, R.K., NORDHEIM, A., and DITTMER, J. (2003). Splicing variant Delta VII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells. Int. J. Oncol. 22, 849-853.
2. BUSSEY, K.J., KANE, D., SUNSHINE, M., NARASIMHAN, S., NISHIZUKA, S., REINHOLD, W.C., ZEEBERG, B., AJAY, W., and WEINSTEIN, J.N. (2003). MatchMiner: A tool for batch navigation among gene and gene product identifiers. Genome Biol. 4, R27.
3. CHEN, Y.F., CHIU, H.H., WU, C.H., WANG, J.Y., CHEN, F.M., TZOU, W.H., SHIN, S.J., and LIN, S.R. (2003). Retinoblastoma protein (pRB) was significantly phosphorylated through a Ras-to-MAPK pathway in mutant K-ras stably transfected human adrenocortical cells. DNA Cell Biol. 22, 657-664.
4. COLBRAN, R.J., and BROWN, A.M. (2004). Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr. Opin. Neurobiol. 14, 318-327.
5. DAN, H.C., SUN, M., YANG, L., FELDMAN, R.I., SUI, X.M., OU, C.C., NELLIST, M., YEUNG, R.S., HALLEY, D.J., NICOSIA, S.V., et al. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J. Biol. Chem. 277, 35364-35370.
6. DITTMER, J. (2003). The biology of the Ets1 proto-oncogene. Mol. Cancer 2, 29.
7. DUFFY, M.J., and DUGGAN, C. (2004). The urokinase plasminogen activator system: A rich source of tumour markers for the individualised management of patients with cancer. Clin. Biochem. 37, 541-548.
8. DU, J., SZABO, S.T., GRAY, N.A., MANJI, H.K. (2004). Focus on CaMKII: A molecular switch in the pathophysiology and treatment of mood and anxiety disorders. Int. J. Neuropsychopharmacol. 21, 1-6.
9. KENNEDY, M.A., MORRIS, C.M., and FITZGERALD, P.H. (1989). The oncogene ETS1 is distant from the chromosome 11 breakpoint in leukaemic cells with the t(11;19)(q23;p13). Leuk. Res. 13, 459-463.
10. KOPP, J.L., WILDER, P.J., DESLER, M., KIM, J.H., HOU, J., NOWLING, T., and RIZZINO, A. (2004). Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1., on the promoter of the type II transforming growth factor-beta receptor gene. J. Biol. Chem. 279, 19407-19420.
11. LELIEVRE, E., LIONNETON, F., SONCIN, F., and VANDENBUNDER, B. (2001). The Ets family contains transcriptional activators and repressors involved in angiogenesis. Int. J. Biochem. Cell Biol. 33, 391-407.
12. LIN, S.R., TSAI, J.H., YANG, Y.C., and LEE, S.C. (1998). Mutations of K-ras oncogene in human adrenal tumors in Taiwan. Br. J. Cancer 77, 1060-1065.
13. LIN, S.R., HSU, C.H., TSAI, J.H., WANG, J.Y., HSIEH, T.J., and WU, C.H. (2000). Decreased GTPase activity of K-ras mutants deriving from adrenocortical tumors. Br. J. Cancer 82, 1035-1040.
14. LING, C., SVENSSON, L., ODEN, B., WEIJDEGARD, B., EDEN, B., EDEN, S., BILLIG, H. (2003). Identification of functional prolactin (PRL) receptor gene expression: PRL inhibits lipoprotein lipase activity in human white adipose tissue. J. Clin. Endocrinol. Metab. 88, 1804-1808.
15. MARTIN, M.E., MUNOZ, F.M., SALINAS, M., and FANDO, J.L. (2000). Ischaemia induces changes in the association of the binding protein 4E-BP1 and eukaryotic initiation factor (eIF) 4G to eIF4E in differentiated PC12 cells. Biochem. J. 15, 327-334.
16. MAUPAS-SCHWALM, F., AUGE, N., ROBINET, C., CAMBUS, J.P., PARSONS, S.J., SALVAYRE, R., and NEGRE-SALVAYRE, A. (2004). The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. FASEB J. [Epub ahead of print].
17. METCALFE, A.D., HUNTER, H.R., BLOOR, D.J., LIEBERMAN, B.A., PICTON, H.M., LEESE, H.J., KIMBER, S.J., and BRISON, D.R. (2004). Expression of 11 members of the BCL-2 family of apoptosis regulatory molecules during human preimplantation embryo development and fragmentation. Mol. Reprod. Dev. 68, 35-50.
18. NAHM, D.S., KIM, H.J., MAH, J., and BAEK, S.H. (2004). In vitro expression of matrix metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta1 in human periodontal ligament fibroblasts. Eur. J. Orthod. 26, 129-135.
19. ROTTINGER, E., BESNARDEAU, L., and LEPAGE, T. (2004). A Raf/MEK/ERK signaling pathway is required for development of the sea urchin embryo micromere lineage through phosphorylation of the transcription factor Ets. Development 131, 1075-1087.
20. SHAKOORY, B., FITZGERALD, S.M., LEE, S.A., CHI, D.S., and KRISHNASWAMY, G. (2004). The role of human mast cell-derived cytokines in eosinophil biology. J. Interferon Cytokine Res. 24, 271-281.
21. SHU, Y., BELLO, C.L., MANGRAVITE, L.M., FENG, B., GIACOMINI, K.M., (2001). Functional characteristics and steroid hormone-mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells. J. Pharmacol. Exp. Ther. 299, 392-398.
22. TAKAI, N., MIYAZAKI, T., NISHIDA, M., NASU, K., and MIYAKAWA, I. (2002). c-Ets1 is a promising marker in epithelial ovarian cancer. Int. J. Mol. Med. 9, 287-292.
23. VAN THEMSCHE, C., POTWOROWSKI, E.F., and ST-PIERRE, Y. (2004). Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo. Biochem. Biophys. Res. Commun. 315, 884-891.
24. WEBB, D.J., DONAIS, K., WHITMORE, L.A., THOMAS, S.M., TURNER, C.E., PARSONS, J.T., and HORWITZ, A.F. (2004). FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat. Cell Biol. 6, 154-161.
25. WERNERT, N., RAES, M.B., LASSALLE, P., DEHOUCK, M.P., GOSSELIN, B., VANDENBUNDER, B., and STEHELIN, D. (1992). c-Ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am. J. Pathol. 140, 119-127.
26. K-ras protein. DNA Cell Biol. 21, 21-29.
27. WU, C.H., CHEN, Y.E., WANG, J.Y., HSIEH, M.C., YEH, C.S., LIAN, S.T., SHIN, S.J., and LIN, S.R. (2002b). Mutant K-ras oncogene regulates steroidogenesis of normal human adrenocortical cells by the RAF-MEK-MAPK pathway. Br. J. Cancer 87, 1000-1005.
28. YU, Y., ZHANG, Y.C., ZHANG, W.Z., SHEN, L.S., HERTZOG, P., WILSON, T.J., and XU, D.K. (2003). Ets1 as a marker of malignant potential in gastric carcinoma. World J. Gastroenterol. 9, 2154-2159.
29. ZEEBERG, B.R., FENG, W., WANG, G., WANG, M.D., FOJO, A.T., SUNSHINE, M., NARASIMHAN, S., KANE, D.W., REINHOLD, W.C., LABABIDI, S., et al. (2003). GoMiner. A resource for biological interpretation of genomic and proteomic data. Genome Biol. 4, R28.